Acetylsalicylic acid Recruiting Phase 4 Trials for Nonvalvular Atrial Fibrillation / Strokes Prevention

RecruitingPrevention4 IdentifierTitleDrugs
NCT02168829Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial
NCT01938248Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation
NCT03463317Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical Therapy